Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 766 | 127 | 16.6 | 423 | 55.2 | 169 | 22.1 | 36 | 4.7 | 11 | 1.4 |
2015-2019 | 787 | 130 | 16.5 | 427 | 54.3 | 180 | 22.9 | 38 | 4.8 | 12 | 1.5 |
2014-2018 | 777 | 143 | 18.4 | 400 | 51.5 | 187 | 24.1 | 37 | 4.8 | 10 | 1.3 |
2013-2017 | 775 | 144 | 18.6 | 401 | 51.7 | 181 | 23.4 | 40 | 5.2 | 9 | 1.2 |
2012-2016 | 795 | 142 | 17.9 | 415 | 52.2 | 182 | 22.9 | 46 | 5.8 | 10 | 1.3 |
2011-2015 | 811 | 144 | 17.8 | 429 | 52.9 | 186 | 22.9 | 42 | 5.2 | 10 | 1.2 |
2010-2014 | 794 | 152 | 19.1 | 407 | 51.3 | 181 | 22.8 | 45 | 5.7 | 9 | 1.1 |
2009-2013 | 841 | 165 | 19.6 | 418 | 49.7 | 193 | 22.9 | 53 | 6.3 | 12 | 1.4 |
2008-2012 | 855 | 162 | 18.9 | 423 | 49.5 | 204 | 23.9 | 49 | 5.7 | 17 | 2.0 |
2007-2011 | 833 | 155 | 18.6 | 413 | 49.6 | 204 | 24.5 | 41 | 4.9 | 20 | 2.4 |
2006-2010 | 808 | 158 | 19.6 | 370 | 45.8 | 215 | 26.6 | 41 | 5.1 | 24 | 3.0 |
2005-2009 | 787 | 159 | 20.2 | 352 | 44.7 | 215 | 27.3 | 33 | 4.2 | 28 | 3.6 |
2004-2008 | 740 | 137 | 18.5 | 345 | 46.6 | 205 | 27.7 | 24 | 3.2 | 29 | 3.9 |
2003-2007 | 701 | 134 | 19.1 | 319 | 45.5 | 194 | 27.7 | 20 | 2.9 | 34 | 4.9 |
2002-2006 | 711 | 141 | 19.8 | 310 | 43.6 | 202 | 28.4 | 21 | 3.0 | 37 | 5.2 |
2001-2005 | 739 | 135 | 18.3 | 352 | 47.6 | 194 | 26.3 | 19 | 2.6 | 39 | 5.3 |
2000-2004 | 795 | 140 | 17.6 | 399 | 50.2 | 200 | 25.2 | 19 | 2.4 | 37 | 4.7 |
1999-2003 | 814 | 139 | 17.1 | 412 | 50.6 | 203 | 24.9 | 22 | 2.7 | 38 | 4.7 |
1998-2002 | 849 | 132 | 15.5 | 450 | 53.0 | 203 | 23.9 | 23 | 2.7 | 41 | 4.8 |
1997-2001 | 843 | 136 | 16.1 | 455 | 54.0 | 183 | 21.7 | 23 | 2.7 | 46 | 5.5 |
1996-2000 | 841 | 132 | 15.7 | 458 | 54.5 | 175 | 20.8 | 21 | 2.5 | 55 | 6.5 |
1995-1999 | 804 | 117 | 14.6 | 434 | 54.0 | 162 | 20.1 | 24 | 3.0 | 67 | 8.3 |
1994-1998 | 794 | 107 | 13.5 | 432 | 54.4 | 151 | 19.0 | 27 | 3.4 | 77 | 9.7 |
1993-1997 | 769 | 107 | 13.9 | 406 | 52.8 | 143 | 18.6 | 28 | 3.6 | 85 | 11.1 |
1992-1996 | 769 | 101 | 13.1 | 412 | 53.6 | 143 | 18.6 | 30 | 3.9 | 83 | 10.8 |
1991-1995 | 736 | 95 | 12.9 | 380 | 51.6 | 142 | 19.3 | 32 | 4.3 | 87 | 11.8 |
1990-1994 | 721 | 93 | 12.9 | 362 | 50.2 | 144 | 20.0 | 29 | 4.0 | 93 | 12.9 |
1989-1993 | 699 | 91 | 13.0 | 332 | 47.5 | 138 | 19.7 | 26 | 3.7 | 112 | 16.0 |
1988-1992 | 716 | 83 | 11.6 | 337 | 47.1 | 140 | 19.6 | 34 | 4.7 | 122 | 17.0 |
1987-1991 | 673 | 64 | 9.5 | 312 | 46.4 | 145 | 21.5 | 31 | 4.6 | 121 | 18.0 |
1986-1990 | 659 | 56 | 8.5 | 313 | 47.5 | 139 | 21.1 | 34 | 5.2 | 117 | 17.8 |
1985-1989 | 634 | 46 | 7.3 | 313 | 49.4 | 130 | 20.5 | 36 | 5.7 | 109 | 17.2 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |